Dasa 2Q26 EBITDA rises 53% vs 2Q25 current scope to R$ 446 million; net loss narrows to R$ 35 million

• Dasa posted a net loss of R$ 35 million in 2Q26, narrowing from a loss of R$ 454 million a year earlier on a current-scope basis.
• EBITDA rose 52.6% to R$ 446 million versus 2Q25 current scope, lifting the EBITDA margin to 20.1%, up 5.8 percentage points.
• Gross revenue increased 8% to R$ 2.41 billion on a current-scope basis, led by Diagnostics National, up 9% to R$ 2.21 billion.
• Free cash flow turned positive to R$ 292 million from negative R$ 18 million, while net financial debt after acquisitions payable fell 23% to R$ 5.62 billion.
• Management cited simplification and efficiency gains; it also completed a R$ 700 million 23rd debenture to redeem the 16th issuance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DASA - Diagnósticos da América SA published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.